Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.31B
Enterprise Value5.33B
P/E Ratio19.47
PEG Ratio-0.74
Price/Sales Ratio4.98
Price/Book Ratio1.17
Enterprise/Revenue4.21
Enterprise/EBITDA13.43

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.26
Operating Margin0.3
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.06

Income Statement

Revenue1.15B
Revenue/Share0.97
Gross Profit930.62M
EBITDA357.17M
Net Income278.58M
Diluted EPS0.27

Balance Sheet

Total Cash1.26B
Total Cash/Share1.2
Total Debt6.05M
Total Debt/Equity0
Current Ratio13.36
Book Value Per Share4.1

Price History

52-Week Change-22.54
52-Week High6.77
52-Week Low4.02
Moving Average 50 Days5.36
Moving Average 200 Days5.62

Statistics

Average Volume41.98M
Shares Outstanding1.05B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.13
Trailing Annual Dividend Yield2.7
Payout Ratio0.53
Last Split Factor13:10
Last Split DateMay 10, 2017
AD